The news releases are issued by FUJIFILM Corporation in Japan.
Fujifilm makes no representation that products on these news releases are commercially available in all countries and regions.
Please note that contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.
- Mar 28, 2024
- Fujifilm’s chemical production method Flow Synthesis Method certified as the highest rank in the Fujifilm Group’s certification program “Green Value Products” (FUJIFILM Holdings)
- Mar 27, 2024
- High-end analog instant camera “INSTAX mini 99™”
- Mar 25, 2024
-
Fujifilm Launches New Water-Based Digital Inkjet Press
Targeting for Flexible Packaging Printing Market - Mar 25, 2024
- Fujifilm Unveils New Inkjet Ink featuring proprietary AQUAFUZE Technology, Combining Water-Based and UV-Curable Ink Technology
- Mar 8, 2024
- FUJIFILM Holdings Sets its Highest Record with 27 Products Winning the Internationally Prestigious “iF Design Award 2024” (FUJIFILM Holdings)
- Mar 7, 2024
- Fujifilm launches “FUJINON HZK24-300mm”- Duvo Portable
- Feb 29, 2024
- FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
- Feb 27, 2024
-
Commemorate 90 Years of Fujifilm Group
FUJIFILM Photo Collection II
Capturing the Human Experience: World Photography in the 20th Century (FUJIFILM Holdings) - Feb 20, 2024
- Fujifilm launches “FUJIFILM X100VI”
- Feb 8, 2024
- Fujifilm Announces the Financial Results for the Third Quarter Ended December 31, 2023 (FUJIFILM Holdings)
- Feb 6, 2024
- FUJIFILM Holdings Named to CDP "A List" for Leadership in Climate Action (FUJIFILM Holdings)
- Jan 25, 2024
- Fujifilm Starts Full-Scale Operation of its Production Facility for Basic Material Used in Semiconductor Manufacturing Process
- Jan 24, 2024
- FUJIFILM Cellular Dynamics and Opsis Therapeutics Announce License with BlueRock Therapeutics for iPSC-derived Cell Therapy Candidate
- Jan 22, 2024
- Fujifilm and World Press Photo Foundation Announce Strategic Partnership
- Jan 22, 2024
- Pricing update for data storage media products
- Jan 22, 2024
- Fujifilm Launches New Global Purpose “Giving Our World More Smiles” (FUJIFILM Holdings)
- Jan 15, 2024
- Fujifilm to Invest 6 Billion Yen in its Kumamoto Site for New Advanced Semiconductor Materials Production Facility
- Jan 4, 2024
- FUJIFILM Holdings Supports Those Affected by 2024 Noto Peninsula Earthquake in Japan (FUJIFILM Holdings)
- Dec 14, 2023
- FUJIFILM Holdings’ FY2030 greenhouse gas emission reduction target validated as “1.5°C goal” by the Science Based Targets (SBT) initiative (FUJIFILM Holdings)
- Dec 5, 2023
- Fujifilm to Invest USD 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities